                         SEQUENCE LISTING

<110>  Novo Nordisk A/S
 
<120>  NOVEL N-TERMINALLY MODIFIED INSULIN DERIVATIVES

<130>  8425.204-WO

<150>  EP11194898.0
<151>  2011-12-21

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified Insulin A-chain


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Dimethylglycine

<400>  1

Xaa Ile Val Glu Gln Cys Cys Thr Ser Cys Cys Ser Leu Glu Gln Leu 
1               5                   10                  15      


Glu Asn Tyr Cys Asn 
            20      


<210>  2
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified Insulin B-chain


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Dimethylglycine-phenylalanine

<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Lysine(N(epsilon)-octadecanedioyl-gGlu-OEG-OEG)

<400>  2

Phe Val Cys Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr 
1               5                   10                  15      


Leu Val Cys Gly Glu Arg Gly Phe His Tyr Thr Pro Xaa 
            20                  25                  


